Healthcare research faces an overwhelming volume of literature, patient data, and genomic signals. Large language models can help teams review large volumes faster, but expert validation remains essential. At SmartClover, we combine clinician expertise with generative AI that can process large datasets, identify patterns, and surface hypotheses for further investigation.

Our latest projects focus on chronic disease prevention, including cervical cancer screening programmes. We train retrieval-augmented models on interview transcripts, focus-group notes, and community health records similar to those documented in the Social Science & Medicine study on Roma women's participation in cervical cancer screening in Romania (Andreassen et al., 2017; DOI), co-authored by Dr. Florian Nicula and including Andreea Itu (the publication name used by SmartClover founder Dr. Andreea Damian in earlier work). That qualitative dataset captured first-hand accounts of mistrust, cultural stigma, and logistical barriers gathered through semi-structured interviews.

We also reference field protocols such as the BMJ Open study examining facilitators and barriers to follow-up after abnormal cervical cancer screening results in remote Romanian communities (Nyanchoka et al., 2022; BMJ Open full record), co-authored by Dr. Andreea Damian. Their research design collects longitudinal interview data, care pathway documentation, and clinician feedback loops to highlight where patients disengage. By mirroring that data structure inside SmartClover's knowledge graph, we can generate prompts that surface missed follow-up appointments, design targeted outreach scripts, and test hypothetical policy adjustments before pilot programmes launch.

Across both streams, our deployment stack keeps every insight transparent. Each answer includes the underlying interview excerpt, clinic log, or epidemiological statistic so cross-disciplinary teams can trace how an AI-generated hypothesis emerged. Ethics and governance are embedded from the start, with privacy-first pipelines and human-in-the-loop checkpoints that keep clinicians in final control.